The present invention includes and provides a method of delivering a medicament to an eye of a subject in need thereof a solution, the method comprising: (a) providing droplets containing the medicament with a specified average size and average initial ejecting velocity; and (b) delivering the medicament to the eye, where the droplets deliver a percentage of the ejected mass of the droplets to the eye.

A breathing treatment apparatus delivers breathing gas to a user. The apparatus may be configured to comprise one or more sensors for sensing microbial growth within the apparatus.

The disclosure relates to medical databases, remote monitoring, diagnosis and treatment systems and methods. In one particular embodiment, a system for remote monitoring, diagnosis, or treatment of eye conditions, disorders and diseases is provided. This method generally includes administering a stream of droplets to the eye of a subject from an ejector device, and storing data related to the administration in a memory of the ejector device. The data may then be monitored and analyzed.

A grip apparatus or kit, and methods of use thereof, that includes a grip housing having a cartridge receiving portion and a motor housing mating portion at opposite ends. The cartridge receiving end having dimensioned to receive a needle cartridge. The opposite end dimensioned to receive a motor drive pin of a needling device. The grip apparatus including a resilient barrier within the grip housing, positioned between the cartridge receiving portion and the motor housing mating portion. The resilient barrier comprising a flexible portion that may include alignment structures having concave, convex, stepped configurations, or a combination thereof.

The improvement device provides an oral suction system for use with endo-tracheal tubes. The device provides alternative anti-infective components and a removable and/or disposable external sleeve, both for mitigation or elimination of risks for viral and/or bacterial contamination of the patient and healthcare professional.

Systems and methods for reducing pathogens near an implant are discussed. In some cases, the methods include reducing contaminants in a portion of a patient that has an implant and that is disposed interior to a closed surface of skin of the patient. The method can further include placing a conduit in the closed surface of skin and flowing an antimicrobial fluid into that portion of the patient to contact the antimicrobial fluid with a surface of the implant and tissue adjacent to the implant. In some cases, the antimicrobial fluid is then removed from the portion of the patient having the implant. As part of this method, biofilm near the implant can be mechanically, ultrasonically, electrically, chemically, enzymatically, or otherwise disrupted. Other implementations are described.

Disclosed herein is a molecular imprinted protective face mask comprising a supportive structure, a surface material that receives and retains a molecular imprint and that is positioned to contact airborne molecules during use, a molecular imprint of a bioactive molecule wherein an imprinted cavity is at least one of a bioactive molecule with a molecular configuration that captures a specific airborne and/or microdroplet-borne molecule and a protein with a binding site that captures a specific molecule.

A toilet comprising a seat for supporting a user during use of the toilet, a bowl for catching excreta from the user, a retractable bidet wand adapted to extend after excretion has concluded, a bidet head located on the end of the bidet wand, adapted to spray water on the exposed surface of the user, an image sensor on the bidet wand, adapted to capture images of the exposed surfaces of the user, and a processor to analyze the images to detect health issues.

A system for supplying power transcutaneously to an implantable device implanted within a subject is provided. The system includes an external connector including one of a microneedle array and a microwire holder. The system further includes a power cable electrically coupled to the external connector and configured to supply power to the one of the microneedle array and the microwire holder, and an internal connector configured to be implanted within the subject and electrically coupled to the implantable device, the internal connector including the other of the microneedle array and the microwire holder. The microneedle array includes a plurality of electrically conductive microneedles, the microwire holder includes a plurality of electrical contacts, and the microwire holder is configured to engage the microneedle array such that the plurality of electrically conductive microneedles extend through the skin of the subject and electrically couple to the plurality of electrical contacts.

The present invention provides a needle unit (10) for use with a pen injection device, wherein the needle unit (10) comprises a needle shield (50) and an axially movable needle hub (25).